Menu
ncarol.com
  • Home
  • Books
  • Book Release
  • Technology
  • Education
  • Health
  • Music
  • Business
  • Financial
ncarol.com

Prime Healthcare, EmVenio Research and Health Wizz Announce Strategic Partnership and Launch of EmVenio Research Center at Prime Healthcare
ncarol.com/10258250

Trending...
  • UK Financial Ltd Executes 100% Success Rate on All ERC-3643 Transfers to Coin Holders of MayaCat Regulated Security Token and Maya Preferred PRA
  • Federal indictments bring new scrutiny to SPLC practices and highlight the real‑world impact of its designations on nonprofit groups, including NCFM
  • Could You Make a 2026 World Cup Squad? A New Free Tool Will Tell You Where You'd Sit on Any National Team's Bench in 90 Seconds
DURHAM, N.C., April 16, 2024 ~ Prime Healthcare and EmVenio Research have joined forces to launch the EmVenio Research Center at Prime Healthcare, a new initiative that aims to improve access to clinical research for patients while also expanding the research capabilities of Prime Healthcare hospitals.

EmVenio Research, a community research provider, will now have the opportunity to conduct research at Prime Healthcare hospitals and offer patients improved access to clinical trials. This partnership is expected to increase participation in clinical trials by creating awareness of research within communities and providing local access to global research opportunities.

With 44 hospitals and over 300 outpatient locations across the United States, Prime Healthcare is one of the nation's leading health systems. Known for its commitment to quality excellence and innovation, Prime Healthcare will provide the necessary infrastructure and clinical support for EmVenio Research to conduct advanced clinical trials.

Through this collaboration, EmVenio will work with Prime Healthcare hospitals to identify potential candidates for clinical trials using Health Wizz. This secure platform connects with Electronic Health Records (EHR) systems, protecting patient data while streamlining the process of identifying, screening, and enrolling study participants. All data collected will be kept secure and used only with patient consent.

More on ncarol.com
  • Underground but Unforgettable — Ms. Salena's Growing Buzz Continues with New Releases
  • TOLI North America's iNStride Versa Combines Safety, Durability, and Design for Commercial Kitchen
  • Buzzblender Announces Launch of Simple Hotel Mode for Android and Upcoming Video Wall Support for Samsung Professional Displays
  • How Strategic WooCommerce Development and Digital Marketing Helped a Fashion Ecommerce Business Increase Revenue by 3X
  • VIV Welcomes Residents to St. Petersburg's EDGE District

Thad Wolfram, President of EmVenio Research, expressed his excitement about this partnership stating that their priority is delivering value to communities while successfully enrolling and retaining patients for their customers. He believes that through this collaboration with Prime Healthcare and Health Wizz, EmVenio will expand its community-based research footprint and be able to recruit an ever-growing patient base for clinical trials.

Dr. Sunny Bhatia, President and Chief Medical Officer of Prime Healthcare, also shared his enthusiasm about this partnership. He believes that EmVenio's expertise in designing and implementing clinical studies will keep the EmVenio Research Center at Prime Healthcare at the forefront of medical research and discovery. Dr. Bhatia hopes that by offering these opportunities to patients at Prime hospitals, they will have better clinical experiences and outcomes.

Nitin Desai, MD, President and Chief Medical Officer of Health Wizz, also expressed his pride in being a part of this visionary collaboration. He believes that by integrating their technology solutions, they can enhance the efficiency and security of enrolling study participants in clinical trials, ultimately benefiting both patients and researchers.

More on ncarol.com
  • Evocative Joins the Independent Data Centre Network (IDCN) as Primary USA Operator
  • Medical Experts Highlight the Importance of Second Opinions in Death Investigations
  • Joseph Nybyk aka Neibich of Gilbert, Arizona
  • Omnitronics Unveils 100% Software omniGateDMR and omniGateP25 RoIP Gateways
  • KRE PRIME Launches Adaptive Convertible Jumpsuit

The EmVenio Research Center at Prime Healthcare will make clinical research available to patients at Prime hospitals across the country, starting with California, Alabama, Texas, and Georgia. This will provide clinical trial sponsors and Contract Research Organizations (CROs) with access to a large and diverse patient population that was previously unavailable to them. With the detailed data available through this partnership, it is expected that there will be improved study feasibility, leading to reduced screen failure rates and increased enrollment certainty.

This service offering includes a hybrid approach that seamlessly integrates brick-and-mortar sites, mobile sites, and in-home research. This unique collaboration between EmVenio Research, Prime Healthcare, and Health Wizz marks a significant milestone in EmVenio's evolution and service repertoire.

Wolfram believes that the EmVenio Research Center at Prime Healthcare will set them apart for patients, communities, partners, and clients alike. This partnership is expected to bring about positive changes in the world of clinical research by providing better opportunities for patients while also expanding research capabilities for healthcare providers.
Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Lansdowne Photographer Steven Weisz Selected for Philadelphia City Hall Exhibition
  • Federal indictments bring new scrutiny to SPLC practices and highlight the real‑world impact of its designations on nonprofit groups, including NCFM
  • Shedrack Anderson Releases New Album
  • Could You Make a 2026 World Cup Squad? A New Free Tool Will Tell You Where You'd Sit on Any National Team's Bench in 90 Seconds
  • Sugar Land's Social Scene Gets a Boost: Pep's Backyard Set to Open Near Constellation Field
  • Joseph Nybyk (AKA Joseph Neibich) Guests On Octopus TV
  • New from Regal House Publishing, Minerva, a girl raised in a politically divided country
  • Mutant-Fueled Bio-Cyberpunk Shooter HoverGrease 2 Launches May 22
  • Triple-Digit Growth, OTCQX Market Upgrade and a Rapidly Expanding Specialty Healthcare Platform: Cardiff Lexington Corporation: Stock Symbol: CDIX
  • XRPPower Continues Strengthening Its Global AI-Powered Blockchain Ecosystem
  • Lick Introduces Pineapple Flavored Massage Oil — A Tropical Date Night Favorite Available on Amazon
  • FutureLot Powers ADU Wizard for Massachusetts Clean Energy Center's Statewide ADU Resource Center
  • ICT Innovations Releases ICTPBX Community Edition as Open Source Under Mozilla Public License 2.0
  • BundleSpy.com lanunches new AI search report
  • Maryland Personal Injury Firm Earns National Recognition in 2026 ELA Awards
  • Robert J. Bradshaw's AYE is a Gripping Dual Reality Thriller Exploring the Increasingly Blurred Line Between Humanity and Technology
  • Bangxing Silicone Revolutionizes Silicone Baby Product Partnerships: Low MOQ Support + VIP Long-Term Win-Win Programs
  • SteelTree Announces Launch of Its Operational Decision Intelligence Service
  • Advanced AI Capabilities Reflected by Upcoming Company Name and Stock Symbol Change for Evolving Pre-Owned Boat Dealer: Off The Hook YS: N Y S E: OTH
  • AI-Driven Defense Expansion, Autonomous Systems and Israeli Aerospace Manufacturing Platform: VisionWave Holdings (N A S D A Q: VWAV)
_catLbl0 _catLbl1

Popular on ncarol.com

  • Altruvest and Financial Executives International Canada Announce Strategic Partnership to Strengthen Nonprofit Boards Across Canada - 115
  • Virginia Moving Company Nearly Doubles Customer Calls in Two Weeks After Switching to CARL — the Bold New Alternative to WordPress - 114
  • RAS AP Consulting Advances to RFP Stage in Heidelberg Materials' SAP Vendor & Customer Master Data Modernization Initiative - 101
  • CCHR Report Links 145 Violent Incidents to Psychiatric Drug Exposure, Urges National Oversight and Action
  • 5,521 College Athletes Launch Own Merch Stores in Just 30 Days on AthleteMerch.com, Reaching 7,975 Live Storefronts Nationwide
  • T. Jones Group's Cameron Jones Serves as Judge for the 2026 CHBA National Awards for Housing Excellence
  • UK Financial Ltd Executes 100% Success Rate on All ERC-3643 Transfers to Coin Holders of MayaCat Regulated Security Token and Maya Preferred PRA
  • $10 Million Annual Revenue Merger, Profitable Partner in AI Powered Specialty Automotive Sales Projected to Scale Above $200M: Stock Symbol: NWPG
  • A Hidden Magical World Awaits in Ashley Gayheart's Upcoming Young Adult Fantasy, Rosewood Academy: The Awakening
  • $29.8 Million Record Setting Q1 with Boosted Annual Guidance to $160 Million for Expanding Pre-Owned Boat Dealer: Off The Hook YS, Inc. N Y S E: OTH

Similar on ncarol.com

  • 50 Million Years of Leadership Wisdom, Now in a Field Guide
  • KRE PRIME Launches Adaptive Convertible Jumpsuit
  • Sobreseimiento de Nicolás dos Santos y Jorge Méndez expone demandas millonarias a Paraguay y boicot a la Hidrovía
  • UK Financial Ltd Executes 100% Success Rate on All ERC-3643 Transfers to Coin Holders of MayaCat Regulated Security Token and Maya Preferred PRA
  • Global.ai Appoints Freedomtech Solutions as Specialist Partner for Agentic AI
  • Triple-Digit Growth, OTCQX Market Upgrade and a Rapidly Expanding Specialty Healthcare Platform: Cardiff Lexington Corporation: Stock Symbol: CDIX
  • XRPPower Continues Strengthening Its Global AI-Powered Blockchain Ecosystem
  • Advanced AI Capabilities Reflected by Upcoming Company Name and Stock Symbol Change for Evolving Pre-Owned Boat Dealer: Off The Hook YS: N Y S E: OTH
  • AI-Driven Defense Expansion, Autonomous Systems and Israeli Aerospace Manufacturing Platform: VisionWave Holdings (N A S D A Q: VWAV)
  • Raymond Lavine, Extended Care Benefits Advisor and Author, to Appear on National Television Series Moving America Forward
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute